Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 37.94 | N/A |
| PEG Ratio (TTM) | 25.30 | N/A |
| P/S Ratio (TTM) | 7.49 | N/A |
| P/B Ratio (TTM) | 24.22 | N/A |
| P/FCF Ratio (TTM) | 30.65 | N/A |
| Price to 5YR AVG Earnings Ratio | 256.15 | N/A |
| Price to 5YR AVG FCF Ratio | 45.36 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 18.50% | N/A |
| ROE (TTM) | 70.08% | N/A |
| Net Profit Margin (TTM) | 19.75% | N/A |
| ROIC 5YR AVG | 556.99% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 142.82% | -164.11% | -23.84% |
| Revenue | 3.83% | 2.86% | 3.50% |
| Net Income | 141.55% | -166.08% | -26.50% |
| Cash Flow | 17.60% | 21.12% | 15.83% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.20 | N/A |
| Quick Ratio (TTM) | 1.20 | N/A |
| D/E Ratio (TTM) | 0.02 | N/A |
| Interest Coverage (TTM) | 198.41 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 5.63 | N/A |
| LTL to 5YR AVG FCF | 0.05 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.85% | N/A |